KROS Competitors & Alternatives
Compare Keros Therapeutics Inc with similar stocks in the same industry
Biotechnology
KROS
Main Stock$9.54
Tradestie Score
55
Market Cap
$620.60M
Revenue Growth
1.8%
Analyst Upside
+107.9%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.77
|
$240.89M | - | 41 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$5.10
|
$231.77M | - | 44 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$11.41
|
$227.00M | - | 42 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$8.42
|
$211.22M | - | 59 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.34
|
$202.58M | - | 34 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.76
|
$199.71M | - | 41 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.78
|
$158.43M | - | 56 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.00
|
$154.27M | - | 48 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.25
|
$133.50M | - | 29 | Compare |
More KROS Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry